After Fontan repair in children, we performed a prospective, open-labe
l study to evaluate the effect of amrinone on pulmonary vascular resis
tance (PVRI). Eight patients who underwent the Fontan repair had basel
ine arterial pressure, left atrial pressure, central venous pressure,
and cardiac output measured postoperatively. Hemodynamic measurements
were repeated after amrinone 4.5 mg/kg. The PVRI tended to decrease, b
ut the change was not statistically significant. Although the systemic
vascular resistance decreased to 802 +/- 222 from 941 +/- 191 dynes .
s . cm(-5). m(-2) (P < 0.05), mean arterial blood pressure was unchan
ged. Cardiac index (3.8 +/- 1.2 to 4.7 +/- 1.6 L . min(-1). m(-2)) and
stroke volume index (23.6 +/- 6.7 to 30.5 +/- 8.1 mL . beat(-1). m(-2
)) increased, and heart rate decreased (160 +/- 21 to 151 +/- 24 bpm)
(P < 0.05). Colloid transfusion during amrinone bolus administration w
as 13.9 mL/kg. The mean serum amrinone concentration was 4.2 mu g/mL a
t the end of bolus and clearance was 2.24 mL . kg(-1). min(-1). Arrhyt
hmias and thrombocytopenia were not noted. We conclude that amrinone a
dministration is effective in increasing cardiac output in children wh
o have undergone a Fontan repair.